Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis

Transplantation and Cellular Therapy(2020)10.1016/j.bbmt.2020.10.009Source: DataRank Database

Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis is a research paper published in Transplantation and Cellular Therapy (2020). On theSindex it has a DataRank of 0. It has been cited 45 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access45 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: hybridTopics (12)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Jessica Flynn ORCID,Lauren DeRespiris,Bradley Figgins,Meagan Griffin,Carmen Lau

Live enrichment

PubMed:33053449 PMC:PMC8441845

NCATS NIH HHS

Grant: UL1 TR002384

NCI NIH HHS

Grant: P30 CA008748

NHLBI NIH HHS

Grant: K23 HL140134

National Institutes of Health

hybridLicense: cc-by-nc-nd

publisherhttps://doi.org/10.1016/j.bbmt.2020.10.009

publisherhttps://api.elsevier.com/content/article/PII:S1083879120306637?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1083879120306637?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8441845

MeSH Terms

HumansCytomegalovirusGraft vs Host DiseaseAcetatesCyclophosphamideQuinazolinesHematopoietic Stem Cell TransplantationAdult

Keywords

ProphylaxisLetermovirCytomegalovirus, Mismatached Unrelated DonorHaploidentiacl Allogeneic Hematopoietic Cell Transplantation

Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis

FAIR Checklist

Authors (16)

Funding (4 grants)

Open Access

Topics

Annotations (Europe PMC)